Shining a light on clinical spectroscopy : translation of diagnostic IR, 2D-IR and Raman spectroscopy towards the clinic by Butler, Holly J. et al.
Shining a light on clinical spectroscopy: Translation of diagnostic IR,
2D-IR and Raman spectroscopy towards the clinic
Holly J. Butler a,b,*, James M. Cameron a, Cerys A. Jenkins c, Gordon Hithell d,
Samantha Hume d, Neil T. Hunt e,d, Matthew J. Baker a,b,*
aWestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow, G1 1RD, UK
b ClinSpec Diagnostics, University of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow, G1 1RD, UK
c Swansea University Medical School, Institute of Life Science, Swansea University, Swansea, UK
d Department of Physics, University of Strathclyde, SUPA, 107 Rottenrow East, Glasgow, G4 0NG, UK
e Department of Chemistry, York Biomedical Research Institute, University of York, Heslington, York, YO10 5DD, UK
A B S T R A C T
In recent years, the application of vibrational spectroscopy in biomedical research has rapidly expanded; covering
aspects of pharmaceutical development, to point-of-care technologies. Vibrational spectroscopy techniques such as
Fourier-transform IR (FTIR), and Raman spectroscopy have been at the forefront of this movement, with their
complementary information able to shine light onto a range of medical applications. As a relative newcomer to
biomedical applications, two-dimensional (2D)-IR is also gaining traction in the field. Here we describe the recent
development of these techniques as analytical tools in medical science, and their relative advancements towards the
clinic.
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Introduction
Vibrational spectroscopy is able to elucidate a wealth of biochemical,
molecular and structural information from biological molecules by
monitoring the interaction of light with chemical bonds. Using
spectrometers, the defined energy required to enable molecular
excitation can be recorded as a spectrum, which behaves as a ‘biochemical
fingerprint’ of the sample being investigated, with each band corre-
sponding to a known molecular entity. For biological samples, which are
often inherently complex in their biochemical composition, vibrational
spectroscopy is able to shine light on subtle chemical differences and
holistically characterise the sample under investigation.
The biomedical applications of such vibrational spectroscopy
techniques are wide; from monitoring drug efficacy to disease diagnostics
[1,2]. A variety of vibrational spectroscopy techniques are able to derive
chemical information, each of which with characteristic features that are
complementary to clinical translation [3]. Fourier-transform IR (FTIR)
spectroscopy and Raman spectroscopy are commonly documented as
primary approaches, with each of these techniques having a variety of
additional sampling modes that enhance experimental capabilities. This
includes suitable analysis of different sample types, including tissues,
bodily fluids, and cells; as well as the ability to define the experimental
output, such as in the form of spectral images [4].
The potential of such techniques in the field of biomedical
science, alongside the development of computational methods for
spectral analysis, has spurred an array of proof-of-concept studies [5].
Due to the complexity of a biological dataset, computational
approaches have allowed exploratory analysis of data, as well as
deep learning and pattern recognition. Ultimately, the goal for
many of these studies is translation into the health services,
or integration into standard protocols. Whilst many of these
studies have advanced the field and brought clinical translation
closer, as of yet, no single application has paved the way [6]. It has
been suggested that this may be due to lack of understanding of the
clinical pathway [7], although is more likely attributed to the
multitude of hurdles along this pathway to translation including
health technology assessments, regulatory approval, prototype
development, clinical feasibility and of course, ever elusive funding
(Fig. 1).
As the field of biomedical FTIR and Raman spectroscopies expand, the
emergence of complementary techniques have also arisen. Non-linear
two-dimensional (2D)-IR for example, has only recently been applied to
biomedical investigations and may well follow suit with regards to
clinical translation. Here we describe the progress of FTIR, Raman and
2D-IR spectroscopies as medical technologies, with particular emphasis
on advanced applications.
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Fourier-transform infrared spectroscopy
IR spectroscopy is based upon the principle that molecules absorb
frequencies of light in the IR range. When this occurs, molecules move
from the ground vibrational state (n = 0) to the first excited vibrational
state (n = 1). This transition requires a quantised amount of energy and
thus can only occur when an incident photon exactly matches this energy
[8]. Specifically, mid-IR spectroscopy focuses upon the region of the
electromagnetic spectrum between 2.5–25 mm, that matches the
frequency of known biochemical bond vibrations [9].
Chemical bonds are known to vibrate in their ground state. Photon
absorption triggers the molecule to vibrate at a higher vibrational
state, causing chemical bonds to stretch apart or bend, altering the
bond angle [10]. These distinct vibrations, known as vibrational
modes, are dependent upon the structure of the molecule under
investigation. A linear molecule with N number of atoms, will exhibit
3 N – 5 modes, whereas a non-linear molecule will have 3 N – 6 modes
[11]. However, not all vibrational modes of a molecule can be
identified using IR spectroscopy. To be considered IR active, a
molecular vibration must exhibit a change in dipole moment – the
charge distribution across the molecule – as it undergoes the
transition [12]. For this reason, polar bonds such as those of water
are always IR active, whereas non-polar bonds are only active when
their vibrations are non-symmetrical.
Fig. 1. Translational research in the field of vibrational spectroscopy. An overview to technical considerations along the pathway to translation.
Table 1
FTIR sampling modes used for analysing biological materials.
Sampling Mode Positive Features Negative Features Tissue Analysis Biofluid Analysis
High quality spatial
information
Susceptible to water
interference
[23] M.J. Baker et al., Journal of
Biophotonics, 2 (2009) 104-113.
[26] H. Fabian et al., Journal of
Biomedical Optics, 10 (2005) 1-10.
High quality signal-to-noise
ratio (SNR)
Need for IR transparent
substrates
[24] P. Lasch et al., Biochimica et
Biophysica Acta, 1688 (2004) 176-186.
[27] C. Hughes et al., Journal of
Biophotonics. 7 (2014) 180–188.
Sample thickness
restrictions
[25] M.J. Pilling et al., Analyst, 140
(2015) 2383-2392.
[28] E. Scaglia et al., Analytical and
Bioanalytical Chemistry. 401 (2011)
2919–2925.
Good quality spatial
resolution
Susceptible to water
interference
[29] K.R. Bambery et al., Analyst. 137
(2012) 126–132.
[32] E. Staniszewska-Slezak et al., An-
alyst. 140 (2015) 2412–2421.
Relatively low-cost reflective
substrates
Spectral artefacts from
reflective substrates
[30] P. Bassan et al., Analyst. 135
(2010) 268–277.
High quality SNR data Sample thickness
restrictions
[31] B. Bird et al., Analyst. 134 (2009)
1067.
Minimum sample preparation Fixed point of analysis
limiting throughput
[33] C. Lima et al., International Journal
of Molecular Sciences. 16 (2015) 6621–
6630.
[36] K. Gajjar et al., Analyst. 138
(2013) 3917.
Substrate not necessary Sample thickness must be
greater than penetration
depth
[34] G. Theophilou et al., Analyst. 141
(2016) 585–594.
[37] J. Hands et al., Journal of Bio-
photonics. 7 (2014) 189-199.
Shorter pathlength allowing
analysis of water
containing samples
[35] M.J. Walsh et al., Vibrational
Spectroscopy. 60 (2012) 23–28.
[38] S. Roy et al., Analytical Chemistry.
89 (2017) 5238-5245.
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Fourier-transform infrared spectroscopy: instrumentation
Traditionally, these bond vibrations were analysed using dispersive IR
instruments. In such systems, the sample is first exposed to polychromatic
light generated by a globar source, which is subsequently directed to a
diffraction grating where the individual wavelengths of light would be
separated out towards the detector [13]. As each wavelength is measured
one at a time, this process was slow and also suffered from throughput
losses. However, the development of FTIR spectrometers in the 1960’s
dramatically changed the approach to IR spectroscopy, improving
analysis times as well as instrument sensitivities [14]. Spectra are
obtained in the frequency domain in dispersive systems, whereas in FTIR
spectrometers spectra are obtained in the time domain, which allows all
the wavelengths of radiation to be monitored at once [15]. This is possible
due to the integration of a Michelson interferometer as well as the
significant advancements in computer technology [16,17].
The development of additional sampling modes and acquisition
capabilities has meant that FTIR spectroscopy is now considered a
powerful and versatile analytical tool. The user generally has the choice
between three major sampling modalities; transmission, reflectance, and
attenuated total reflection (ATR) approaches (Table 1) [18]. Transmis-
sion FTIR spectroscopy observes energy absorption from the sample by
directing the IR beam through the sample, and consequently monitoring
the energy change. This simple approach can yield high quality IR spectra
in a non-destructive manner, although it is also reliant upon the sample
being placed on IR transparent substrates, which are often expensive in
comparison to low emissivity slides used in transflection mode [19].
Furthermore, as light needs to fully traverse the sample, there is a limit to
the sample thickness to allow sufficient detection of the signal [9]. The
preparation steps required for samples in this case can often be time
consuming, and not conducive towards clinical translation.
Contrastingly, transflection FTIR spectroscopy observes the transmis-
sion of IR light through the sample; however, by placing the sample on a
reflective substrate, the light is in fact reflected back through the sample
toward the detector. Transflection has become popular due to the relative
low cost of substrates (aforementioned low emissivity slides), as well as
the higher absorbance obtained due to a double pass through the sample
[20]. However, as with transmission FTIR spectroscopy, there is a limit to
sample thickness, and also the possibility of spectral artefacts due to the
employment of reflective substrates [21].
Alternatively, an internal reflection approach offers the possibility of
substrate-free sample analysis. ATR-FTIR spectroscopy is based upon the
principal of total internal reflection, where the IR beam is reflected within
a fixed crystal, or internal reflection element (IRE), made of a IR
transparent material with a high refractive index (such as diamond,
germanium or zinc selenide) [22]. Traditionally, a sample is placed in
contact with this IRE eliminating the need for a sample substrate. At the
point of reflection within the IRE, the difference in the diffractive indices
of the IRE and sample results in the creation of an evanescent wave at the
IRE-sample interface. This wave penetrates into the sample to a defined
depth allowing photon absorption in the sample which will thus attenuate
the incident light [18]. With a smaller pathlength of light, defined by the
evanescent wave penetration depth, one benefit of using ATR-FTIR
spectroscopy is the ability to analyse water containing samples, as less
water is sampled. Additionally, as the sampling area is defined by the IRE,
the spectra obtained are from a larger sample area. For heterogenous
samples with inherent architecture, such as tissue samples, spatial
information is not as readily accessible using this sampling mode,
however could provide a ‘macro’ measurement across a defined area.
Adaptations to these standard FTIR spectroscopy methods have also
been further developed this technique in the biomedical field. The
addition of a microscope for instance has allowed the focusing of IR light
on microscopic sample areas, providing high spatial resolution data
[39,40]. The use of alternative light sources, such as broadband radiation
with high flux density from a synchrotron source or quantum cascade
lasers (QCL) that can provide rapid discrete frequency sampling, can also
provide greater sensitivity when measuring biological samples. The
development of imaging technologies, largely based upon the detector
capabilities in the spectrometers, have also allowed greater flexibility in
spectral acquisition [41].
Fourier-transform infrared spectroscopy: clinical applications
There have been many proposed clinical applications of FTIR
spectroscopy, yet the majority have been limited in their development.
Here we describe the most advanced of these applications and present
their progress towards translation into the clinic.
One such application is the development of spectral histopathology.
Histopathology is a process within disease diagnosis pathways where a
trained pathologist observes changes in tissue structure at a microscopic
scale. Whilst this is considered gold standard, the subjective nature of this
approach often results in a lack of consensus between pathologists [42–
44]. Integration of ‘spectropathology’ into the current clinical pathway
may reduce this operator variability, particularly in marginal cases,
whilst also improving time efficiency during the process. The imaging
capabilities of FTIR spectroscopy allow visual classification of tissue
samples, with clear differentiation between tissue features, as well as the
presence of diseased or cancerous tissue. This approach has proven
valuable in exploring prostate tissue, differentiating between benign and
malignant epithelium, as well as other tissues including colon, lung and
brain tissues [45,46–48]. However, it is worth noting that tissue analysis
often requires significant sample preparation steps, particularly when
using pathlength dependent FTIR modalities – such as transmission or
transflection.
The rapid determination of cancerous tissue is useful for determining
tumour margins and could be a useful intra-operative aid [48]. However,
it is noticeable that FTIR spectroscopy have been relatively limited to ex
vivo applications, although novel light sources may extend this technique
to other applications [49]. QCLs as an example, have significant speed
advantages over traditional thermal light sources; allowing discrete
frequency scanning [50]. A significant hurdle in translation of this
application is the choice of an appropriate sample substrate that results in
spectra of sufficient quality and also fits within cost restrictions in health
services. IR transparent (or reflective) substrates, such as calcium fluoride
windows, provide optimum spectral quality yet fail with regards to cost-
effectiveness [19]. A recent study presented the analysis of routine
pathology samples obtained from prostate samples; sectioned onto glass
slides with coverslips and stained with eosin and haematoxylin [51]. This
promising study shows a non-disruptive application of spectroscopy that
is complementary to traditional pathology; minimising widespread
changes to the clinical pathway. Whilst disruptive technologies may
initially excite the markets they enter, in the case of medical technologies
disruption to the current clinic practise can become a significant barrier to
translation [52].
Another established application is in field of spectral cytology, or
“spectrocytology”, where FTIR spectroscopy has been explored as a
complementary, or even alternative, technique to cytological screening
[49]. A number of early studies investigated FTIR spectroscopy as a tool
for aiding the detection of cervical cancer. This area has since expanded
dramatically with more recent studies achieving greater granularity, such
as determining the spectral response of cervical cancer cell lines to human
papillomavirus [53–56]. Furthermore, cells exfoliated from oral tissues
have also been shown to be effective in the diagnosis of oropharyngeal
and laryngeal cancers [57]. A number of aspects of spectrocytology make
it well suited to the clinic; samples are generally easy to obtain and the
opportunity to adjunct onto existing screening programmes make it an
attractive target for translation. However, there remains no clear
advancement towards a clinical setting. Whilst it is possible to obtain
high quality spectra across most modalities of FTIR spectroscopy, barriers
to translation could potentially be; (i) a requirement for sample
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preparation to account for inherent water content in cells, (ii)
requirement for sample substrates that may incur costs too high for
health service screening, and (iii) spectral distortions that may arise as a
consequence of Mie scattering [58].
The relative amount of light absorbed by a sample is directly
proportional to the concentration of its molecular components, following
the principles of Beer-Lambert Law. As such, IR spectroscopy can derive
quantitative information which alongside multivariate analysis has
allowed many applications across the clinical field. It has been shown that
analytes within biofluids, such as blood serum, plasma and urine can be
quantified with direct clinical applications [59–61]. For instance, total
protein content of blood serum, which is routinely used as a marker of
disease or infection, can be elucidated using ATR-FTIR spectroscopy;
potentially allowing rapid, and label free monitoring of patient health
[62].
The analysis of biofluids is a significant portion of the clinical IR
spectroscopy field, with a wide range of diagnostic applications [63].
Biofluids represent an ideal medium for diagnostic tests as they can be
acquired without significant invasion (in comparison to tissue biopsies,
for example), and can provide localised or globally representative
information of patient health. Saliva, cerebrospinal fluid, and urine are
examples of organ and system specific biofluids; whereas blood and its
derivatives, such as plasma and serum, can provide body-wide
information. Due to this, liquid biopsies are largely considered the ‘holy
grail’ of early disease detection; with increasing scientific research and
media coverage in recent years, particularly in the area of cancer
diagnostics [64]. However, the majority of research in the field of liquid
biopsy is centred around discrete biomarker identification; the search for
a known entity that is confirmatory of disease [65]. Whilst this has been
shown to be diagnostically accurate, particularly in the case of circulating
tumour DNA, there are a number of limitations to this approach [66].
Significantly, it requires a priori knowledge of the specific biomarker, and
is also limited by population variance that can lower diagnostic
performances [67].
The aforementioned ‘biomolecular fingerprint’ provided by FTIR and
other vibrational spectroscopies may provide an alternative approach for
liquid biopsies. The spectra obtained are representative of the entire
composition of a given biofluid, including any potential diagnostic
biomarkers. In conjunction with multivariate analysis techniques, this
holistic approach is less reliant upon a single biomarker and observes
widespread changes and interactions of diagnostically relevant mole-
cules. This has been shown across a range of biofluids including the
detection of; malignant biliary tissue from bile [68], lung cancer using
sputum [69], and bladder cancer using urine [70]. It is worth noting that
biofluid analysis using IR-based spectroscopies is somewhat limited due
to the inherent water content of the fluids, which can often mask
significant biological information. For this reason analysis of dried
biofluids is preferable [9]. That said, the complex drying patterns that
arise from air-dried biofluid drops, such as the widely-known coffee ring
effect [71], have inhibited successful translation thus far, as the surface
inhomogeneity can cause peak shifts and alterations in band intensities
[72]. Hence, it is vital the drying conditions are controlled and optimal
protocols are developed in order to obtain an even deposition across the
sample [73,74].
Perhaps the most advanced application of FTIR spectroscopy, is the
analysis of blood serum for the detection of brain tumours using ATR-FTIR
spectroscopy [75]. This is due in part to the unmet clinical need for a rapid
diagnostic, which would prevent repeat visits to the general practitioner
(GP) due to misinterpreted symptoms, which often leads to diagnoses
being made in an emergency. Based upon ATR-FTIR spectroscopy
specifically, a small aliquot of serum is placed upon the IRE, spectra are
collected, and the subsequent dataset is then analysed using machine
learning. This approach yields a diagnostic result dependent upon the
clinical question (for example, cancer versus non-cancer, primary versus
secondary cancers etc.) alongside a prediction of accuracy, or confidence
in the given result, to aid in the clinical decision making [76].
An important consideration for applications such as this is the
indication of use. In this example, the implications of an absolute
diagnostic versus a triage method have been explored by mapping the
diagnostic pathway for brain tumours, with the opportunities as a triage
tool in primary and secondary care measured in terms of cost savings to
the health service as well as the impact on quality of life [77]. In primary
care, such a test would allow a GP to investigate a patient’s symptoms,
without immediate referral to secondary care, where there is already
increased demand on expensive neuro-imaging equipment such as CT and
MRI scanners. In secondary care, this test would allow patients with
suspected brain tumours to be imaged more rapidly, allowing faster
diagnosis and consequently prompt treatment. Interestingly, this
approach moves away from point-of-care testing, where health economic
benefits could potentially be negligible [7].
This is one example where research has been actively commercialised
for the purpose of improving the clinical pathway and impacting patient
health; in this case, a Scottish based university spin-out called ClinSpec
Diagnostics Ltd. There has also been the formation of several other
commercial entities employing IR technologies for similar purposes,
including; CIRECA (US), for FTIR-based tissue imaging and biomarker
identification [78], Beamline Diagnostics (UK) for ATR-FTIR spectrosco-
py of bulk tissue analysis in the operating theatre [79], Glyconics (UK), a
point-of-care diagnostic for COPD using FTIR-based analysis of mucus
[80], and also Biotech Resources (Aus) for infectious disease detection
[81].
This latter commercial entity has recently made significant advance-
ments towards translation, with exciting studies on malarial detection in
the field [82]. The technology employs ATR-FTIR spectroscopy for the
analysis of whole blood samples, which are freeze-thawed, and deposited
upon a glass slide [83]. This approach has been shown to not only indicate
presence of infection, but also provide a quantitative estimate of malarial
parasitaemia, as well as blood urea and glucose levels [38]. An interesting
aspect to this approach is the use of glass slides, which negates the need for
expensive IR substrates that would otherwise inhibit uptake in remote
locations.
Raman spectroscopy
Raman spectroscopy (RS) relies on the inelastic scattering of incident
light upon a sample. In biological samples, such as tissue and biofluids, the
majority of incident light on the sample is elastically scattered known as
Rayleigh scattering [84]. A small proportion of the light (around 1 in 107)
is inelastically scattered, resulting in a difference in energy between the
incident photon and the scattered photon [85]. The energy difference in
the scattered light corresponds to the transitions between vibrational
energy levels within the molecules, and the bands that are observed in
Raman spectra relate to the different vibrational and rotational modes of
the molecules present within the sample.
Similar to IR, a Raman spectrum provides a wealth of biochemical
information from a sample. Due to different selection rules that govern the
scattering process – for example, change in polarizability vs change in
dipole moment – Raman spectroscopy can yield complementary
information to IR spectroscopies. This is significant when considering
that water is a strong IR absorber, whereas water molecules have a small
Raman cross section when interrogated with visible wavelength
excitation. The minimal water interference within Raman spectra has
allowed Raman spectroscopic analysis of clinical samples such as liquid
biopsy specimens [86].
Raman spectroscopy: instrumentation
One of the first instrumental developments for clinical applications
was the coupling of a Raman spectrometer to a microscope for
applications to pathologic specimens in the 1970s [87]. Through
advances in laser excitation sources and improvements in charge-coupled
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device (CCD) detectors, Raman microspectrometers are now commer-
cially available and have been applied to a range of different biomedical
applications; such as live cellular imaging, pathologic tissue analysis and
biofluid analysis [88–91].
As Raman microspectroscopic imaging commonly uses dispersive
detection, which is rather inefficient when collecting images (minutes per
frame), it can limit real time analysis of dynamic processes, particularly
across large areas and/or over short periods of time. Moreover,
microscopy-based techniques rely on light being collected through
objective lenses, which typically have a smaller field of view than the
sample being imaged (e.g. tissue sections). This latter point is not
exclusive to RS, with FTIR microspectroscopy approaches also encoun-
tering this limitation. To combat these problems, coherent Raman
spectroscopy (CRS) techniques have become of interest in the field [92].
Two of these processes, stimulated Raman scattering (SRS) and coherent
anti-Stokes Raman Scattering (CARS), can overcome issues with Raman
imaging of biological systems due to their potential speed and spectral
resolution. The technological developments in SRS and CARS imaging for
biological systems have been reviewed in depth elsewhere [92–94].
Furthermore, a recent review article on the potential for transmission
Raman highlights the use of spatially offset Raman spectroscopy (SORS)
and surface enhanced spatially offset Raman spectroscopy (SESORS) for
completely non-invasive imaging and disease monitoring at depth
through tissue [95].
An alternative method for analysing biological samples is through
Raman fibre-optics. Fibre-optic systems have great potential for rapid,
non-destructive, real-time in-vivo and ex-vivo tissue analysis, due to their
ability to effectively excite samples and collect a spectrum from a single
point. The flexibility of fibre-optic systems has enabled them to be
developed and integrated into a range of medical systems, such as contact
probes, endoscopes and needle based probes [96]. Weaknesses in signal
strength in Raman instrumentation can be overcome by using enhanced
Raman techniques such as resonant Raman (RR) and surface enhanced
Raman spectroscopy (SERS) [97]. RR takes advantage of the internal
resonance of molecules within a biological sample to the excitation
wavelength to enhance scattering effects [98,99]. SERS utilises
plasmonic nanostructures to enhance the Raman response of a given
analyte. RR and SERS have both also been developed for a range of clinical
applications in conjunction with different Raman instrumentation [100].
Raman spectroscopy: clinical applications
Much like FTIR spectroscopy, the majority of RS clinical research has
been aimed at tissue analysis, because of the ability to generate images
representative of tissue morphology and structure. However, due to
having a small water cross-section, there is the potential to apply RS to
tissues in vivo. An early application of RS for in vivo analysis was based on
squamous cell carcinoma characterisation of skin using a microspec-
trometer [101]. More recently, there are a number of clinical applications
of RS that are based upon fibre-optic Raman probe systems for diagnostic
applications. Fibre-optic RS systems have been applied to many in vivo
and ex vivo tissue diagnostic studies, such as the detection of cervical
cancer [102,103], digestive cancers and precursor lesions [104–107],
oesophageal cancers [108–110] and real-time diagnosis of nasopharyn-
geal cancer [111]. The application of rapid real-time feedback from fibre-
optic systems highlights the potential use as a method of surgical
guidance. A study by Jermyn et al. reported a needle-based Raman probe
for inter-operative use in brain tumour resection [112], with the group
later reporting the potential for the system to be used for targeted in vivo
brain cancer biopsies [113]. SORS has also shown to be useful in the non-
invasive determination of breast cancer margins [114]. The develop-
ments in non-linear instrumentation has led to faster imaging times,
meaning RS techniques are now somewhat comparable with rapid IR
imaging technology, such as QCL-based spectrometers. Recently, SRS
imaging was applied to resected brain tissue, for the detection of tumour
infiltration, on a small cohort of 22 patients [115].
As with FTIR spectroscopy, RS is well suited to spectrocytology
applications, with cervical and oral cytology studies dominating the field
[116–118]. The major benefit of employing RS in cytology samples, is that
ex vivo analysis is possible due to RS being less sensitive to water content,
compared to FTIR spectroscopy approaches. The ability to automate
instruments, coupled with fast analysis times, means that RS would lend
itself well to screening applications whilst providing sensitive data on
disease status and progression that could potentially improve patient
time-to-diagnosis and ultimately survival [119]. Perhaps the biggest
challenge in this field is competition with relatively inexpensive
screening pathways that are well established in the developed world.
RS has also been applied to the field of liquid biopsies, having the
potential to become a rapid, minimally invasive diagnostic tool for
various types of disease. One significant advantage of RS over FTIR-based
techniques, is that biofluids can be analysed in a liquid state, without the
need for drying. The first application of RS for biofluid analysis was
carried out by Berger et al., where RS was used to analyse whole blood
[120]. Due to the large Raman scattering cross-section of red blood cells in
whole blood, most Raman biofluid studies now focus on serum and
plasma. The potential of RS to differentiate malignant diseases from
healthy control samples using either serum or plasma has been repeatedly
demonstrated. Since early studies from Li et al., who used serum-based RS
and fluorescence for GI cancers [121], there have been numerous proof-
of-concept studies for a range of malignant diseases including breast
cancer [122,123], head and neck cancers [124], colorectal cancer [121],
cervical cancer [125] and hepatocellular carcinoma from cirrhotic
patients [126]. Sahu et al. initially analysed serum samples to try to
differentiate between oral cancer patients and controls [127], then the
group later presented the application of serum RS to detect recurrence of
oral cancers, although this study only included a small number of patients
[128]. The development of high-throughput Raman instrumentation for
diagnosis of prostate cancer in plasma samples has also been reported for
a small patient cohort, which demonstrates the potential for rapid
analysis with high sensitivity and specificity (96.5 % and 95 %,
respectively) [129]. Furthermore, malaria parasites have also been
shown to be measurable through both RS, with some studies reporting
high sensitivity and specificity for detecting low levels of parasitaemia
[82].
RS has also been shown to be an efficient tool for detecting non-
malignant diseases. Differences in the Raman spectra of blood serum
collected from Hepatitis C and healthy patients were observed through
principal component analysis (PCA) [130]. Likewise, patients with
rheumatoid arthritis have been successfully separated from healthy
controls, with a sensitivity and specificity of 96 % and 88 %, respectively
[131].
Despite potential issues with reproducibility and reagent shelf life,
SERS methods for malignant disease detection using biofluids have been
widely reported using both targeted and un-targeted methods [132–135].
A large SERS serum assay for liver disease involving over 700 patients was
recently reported by Shao et al., with an accuracy of 81.76% [136]. SERS
has also been successfully used for the detection of prostate cancer and
UTI identification in urine [137]. Chemical quantification within
biofluids is also possible with RS, which could be a potential route to
clinical translation. Early chemical concentration measurements in blood
serum and urine using liquid-core optical fibre were performed by Qi et al.
[138]. RS has previously been used to measure concentrations of blood
analytes, like cholesterol, in both serum and plasma [139]. The detection
and analysis of carotenoids, such as lycopene and b-carotene, in blood
plasma has also been investigated [140]. Promisingly, SERS-based
immunoassays hold potential for ultrasensitive detection of blood
analytes such as chemokines outperforming standard ELISA tests
[141]. Glucose monitoring in ex vivo serum samples has been possible
using both RS and SERS [142,143], meanwhile a recent study has directly
compared RS and FTIR for glucose measurements in liquid and dried
serum samples, respectively [144]. Liquid biopsies are often described as
non-invasive, but there is an argument that repeatedly extracting blood
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for chemical monitoring could still raise issues for clinical translation. As
such, SORS and SESORS have been used for sub-epidermal glucose
monitoring tools, which if successful could have huge potential for truly
non-invasive biofluid applications [145–147].
Promising results for biofluid RS applications have been reported in
many studies, but few groups have reported developments past proof-of-
concept stages. To push liquid biopsy RS towards translation there will
undoubtedly need to be further development of high-throughput
techniques, as well as larger patient cohort/multi-centre clinical studies
in line with those currently underway for IR applications [77]. Further to
academic publishing, patents have been filed for the application of RS to
colorectal cancer using dried serum samples. CanSense Ltd (UK) are
pursuing this application commercially, with clinical studies currently
underway, displaying one of the first RS based companies working in the
clinical sphere.
2. D-IR spectroscopy
Whilst Raman spectroscopy may overcome some of the challenges of
water containing samples, it is clear that IR absorption methods can be
hindered by intense absorptions of water, which may limit ex- and in vivo
investigation. In particular, the HOH bending vibration near 1650 cm
1 obscures the protein amide I mode that is highly sensitive to secondary
structure. As the protein content of biofluids, such as serum, provides a
useful indicator of metabolic function, the ability to differentiate between
different proteins in a complex aqueous mixture without significant
sample preparation would be a major advance. Recently, it has been
shown that the technique of ultrafast 2D-IR spectroscopy is not only
capable of measuring the amide I band of proteins in transmission mode in
aqueous solvents, but is capable of differentiating and quantifying the
albumin and globulin fractions of as-received blood serum, suggesting
that the method may have considerable potential for biofluid diagnostic
applications.
Since its development in 1998 [148], 2D-IR has been widely used to
investigate the structure and ultrafast dynamics of biomolecules in
solution [149–171]. As a technique, 2D-IR can be thought of as an IR
analogue of 2D-NMR spectroscopy, utilising a train of ultrafast IR laser
pulses to excite molecular vibrations in place of radiofrequency radiation
interrogating nuclear spins. In common with 2D-NMR methods, 2D-IR
places the IR absorption spectrum of a molecule along the diagonal of the
2D plot, while the off-diagonal region reports on couplings between the
vibrational modes [148]. This is important for studies of proteins because
secondary structure elements within proteins give rise to unique 2D
spectral patterns via intramolecular couplings of the peptide carbonyl
groups, meaning that the 2D-IR signal is sensitive to secondary structure
to a greater degree than IR absorption spectroscopy. The short duration of
the laser pulses also enables measurement of sub-picosecond molecular
dynamics. Of particular relevance to applications to biofluids is the fact
that, as a nonlinear optical spectroscopy, the 2D-IR signal scales
quadratically with the vibrational transition dipole moment of the mode
being studied, whereas the IR absorption signal scales with the second
power [171,172]. For an aqueous protein solution this is important,
because in an absorption measurement, the response from the many,
weakly absorbing water molecules overwhelms that from the few strongly
absorbing proteins (the molar absorption coefficient of the amide I mode
of a typical protein is two orders of magnitude larger than that of the
HOH bending mode). In a 2D-IR experiment, the situation is reversed,
meaning that the protein signal dominates, allowing measurement of
protein content of blood serum without drying or alternate detection
geometries. We return to the clinical relevance of this measurement below
following a discussion of the method of acquiring a 2D-IR spectrum.
2. D-IR spectroscopy: instrumentation
A full description of the theory and experimental details of 2D-IR
spectroscopy measurements have been described in several review
articles and so we will focus on the state-of-the-art methodology most
relevant to biofluid analysis [148,172–175].
The 2D-IR method employs a sequence of three IR pulses. Two ‘pump’
pulses and one ‘probe’ pulse are overlapped in a liquid sample that is held
between two IR transmissive windows. The pulses are typically around
50–100 fs in duration, meaning that they cover a spectral bandwidth of
200400 cm1 and are centred at the wavelength region of interest e.g.
the amide I band. The current state of the art technology involves the use
of 100 kHz pulse repetition rate lasers combined with pulse-shaping to
control the timing of the pump pulse pair [176–178].
The combination of the three pulses results in the emission of a signal
pulse from the sample, which is directed into a spectrometer and
dispersed via a grating onto a multi-element array detector. This
frequency dispersal generates the ‘probe’ frequency axis of the 2D-IR
spectrum. By recording the signal as a function of the delay time between
the pump pulse pair (t) and performing a Fourier Transformation, the
second ‘pump frequency’ axis of the spectrum is generated. The resulting
2D spectrum is thus a correlation map of pump frequency versus probe
frequency. The delay time between the pump pair and the probe pulse,
called the waiting time, can also be altered to interrogate the sample at
different waiting times after excitation. Under these conditions, a 2D-IR
spectrum typically requires less than a minute to acquire, comparable
with the time needed for a benchtop FTIR spectrometer.
2. D-IR spectroscopy: clinical applications
Traditionally, 2D-IR spectroscopy studies of biomolecules in aqueous
solutions are conducted using deuterated solvents (D2O), in order to
prevent overlap between the amide I and the OH bending mode of H2O
at around 1650 cm1. Whilst this allows detailed study of the amide I
band, free from water absorption, studies in D2O are not without issue;
this non-physiological solution may not be representative of the
biological sample due to the impact of heavy isotopes on dynamic
behaviour. Furthermore, deuteration is impractical to implement in
biofluids and costly on an industrial scale.
However, it has been shown recently that 2D-IR measurements of the
protein amide I band in aqueous solutions is possible [179]. The FTIR and
2D-IR spectra of the amide I band of a sample of horse serum are shown in
Fig. 2((a) and (b)). Two clear features are visible on the diagonal of the
serum 2D-IR spectrum, marked by black arrows in Fig. 2(b), while the
corresponding water signal (Fig. 2(d)) is significantly weaker. The two
diagonal features were assigned to the n = 0–1 transitions of the amide I
modes of the albumin and globulin protein fractions of the serum. The two
amide I bands are separated in frequency by the differing secondary
Fig. 2. (a) FTIR and (b) 2D-IR spectra of the amide I band of horse serum. (c) FTIR
and (d) 2D-IR spectra of H2O under the same conditions. The H2O 2D-IR signal (d)
has been magnified 50 and is shown on the same scale as the serum spectrum (b).
Figure reproduced from ref. [179] with permission from the Royal Society of
Chemistry.
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structure composition of the proteins (albumin is largely alpha helical,
whereas globulins are dominated by beta sheets). Importantly, the two
features were not separable in the FTIR spectrum (Fig. 2(a)) which shows
only a broad band consisting primarily of the water response (Fig. 2(c)).
The reason for this is that, as well as amplifying the protein signal, the 2D-
IR method leads to a narrower linewidth than FTIR spectroscopy,
enabling greater spectral resolution [172].
Using these diagonal bands, 2D-IR spectroscopy enabled the albumin
to globulin ratio of blood serum to be determined. The 2D-IR results were
compared with current standard measurements for obtaining protein
concentrations and were found to be accurate to within  4 % across a
clinically relevant range. It was also shown that the unique 2D signatures
that derive from protein secondary structure enabled differentiation and
quantification of the similarly structured globulin proteins, IgG, IgA and
IgM in serum [179].
The ability to differentiate small changes in protein secondary
structure using 2D-IR has been demonstrated and this may be powerful in
determining structural changes of proteins during disease states or
allosteric affects due to drug binding. A recent study of the calcium-
binding messenger protein calmodulin (CaM) has shown the capability of
2D-IR to detect small secondary structure changes upon binding of Ca2+
ions [180]. 2D-IR measurements measured a thermally induced reduction
in a-helical content of apo (no Ca2+) CaM. The observed 15 % loss of
helical structure was benchmarked using circular dichroism spectrosco-
py, which measured a 13 % change [181]. Moreover, the ability to detect
a Ca2+-induced change in structure affecting only seven residues of the
150 that make up the protein was reported. These changes in the amide I
band are detectable using IR absorption methods, but they lack the
additional information content of 2D-IR spectroscopy that allows
definitive assignment of the structural origin of the changes. 2D-IR has
also been used to quantitatively determine the secondary structure of a
library of 16 proteins using the 2D amide I lineshape. These measure-
ments were taken without the use of sample labelling and were compared
positively with circular dichroism results [182].
2D-IR has been used to study the effects of drug binding upon protein
structure and dynamics in InhA, an enzyme partly responsible for the
maintenance of cell walls in the bacterium Mycobacterium tuberculosis.
Changes in the off-diagonal portion of the amide I lineshape were found to
correlate with drug-induced inhibition of activity [183]. The technique
has also been shown to reveal amyloid b-sheet-like secondary structures
in ex-vivo porcine cataracts using both off and on diagonal 2D-IR features,
where the current standard technique - transmission electron microscopy
(TEM) - failed to resolve them [154]. Again, this highlights the potential
use of 2D-IR to understand how diseases are manifest, allowing more
accurate and effective treatments. Moving away from proteins to other
biofluid components, the off-diagonal features in a 2D-IR spectrum that
link coupled vibrational modes can be diagnostic of the presence and
quantity of e.g. phospholipids or nucleic acids. For example recent work
on DNA showed the presence of cross peaks linking vibrational modes that
are diagnostic of double stranded DNA [184,185].
Although spectra obtained in 2D-IR spectroscopy experiments can be
obtained in under a minute, giving access to high throughput screening
applications, this can lead to large, complex datasets that require new
approaches to display and analyse the information. In order to allow
translation of 2D-IR towards clinical purposes, handling of the data
obtained has to be efficient in order to return accurate results in a timely
manner. Principal component analysis (PCA) has seen increasing usage as
a tool for extracting information from 2D-IR data sets, such as changes in
structure of proteins or following thermal denaturation of DNA duplexes
[180,184]. A recent study on DNA-ligand binding builds on these
previous studies by combining recent technological advances in 2D-IR
measurement with PCA [186], demonstrating that large dataset analysis
is achievable. These studies show the potential of the rapid, information
rich 2D-IR spectra equipped with the right analytical tools to examine
complex structures, paving the way to determine between disease and
non-disease states in biofluids.
Together, the advances in 2D-IR spectroscopy measurement protocols
and the subsequent analysis of 2D-IR spectra present the possibility of
translating 2D-IR spectroscopy towards medical applications. On the road
to achieving this, a number of important milestones have been reached.
Reliable information can now be extracted from large and complex
biological systems even those that exhibit very small fluctuation in
molecular structure or composition. Further to this, large and complex
datasets can be analysed in a timely manner which is necessary when
processing large numbers of patient samples. The third hurdle crossed is
that of measuring 2D-IR spectra of biological systems in H2O, meaning
that rapid disease diagnosis using unlabelled, as-received serum could be
a future possibility. However, obstacles still need to be overcome in order
to present 2D-IR in a medical setting. Currently, state-of-the-art
instrumentation is expensive, large and requires constant expertise to
maintain good quality spectra. However, with the continuing develop-
ment of 2D-IR and growing of the accompanying community, continual
advances can be made in order to allow 2D-IR to make a significant impact
in medicinal research.
Conclusions
The translation of vibrational spectroscopies towards the clinic has
been advancing alongside technological developments, with proof-of-
concept studies highlighted here providing evidence of numerous clinical
applications. In recent years, there has been a clear movement towards
clinically relevant studies and commercialisation of these technologies;
particularly in the case of FTIR and Raman spectroscopy.
Automated or high-throughput instrumentation would be best suited
to clinical settings, in order to minimise pressure on personnel resource.
For example, ATR-FTIR spectroscopy is inherently limited to a single,
fixed point of analysis, which restricts the overall sample throughput,
particularly when taking into account cleaning the crystal between
measurements. However, the development of low cost IREs may provide a
disposable substrate for ATR-FTIR spectroscopy, similarly enabling batch
processing of samples and high-throughput spectral acquisition alongside
the development of novel instrumentation [187].
The analysis of tissue for the detection of malignant diseases has
yielded a potentially powerful tool to complement traditional histopa-
thology, that can rapidly extract molecular information from heteroge-
neous samples. The major hurdles for such an approach remain disruption
to the current clinical pathway and also the health economic arguments
for implementation.
The analysis of biofluids presents a promising application of both FTIR
and Raman spectroscopy. These homogenous samples are significantly
easier to extract, require minimal preparation prior to analysis, and can
also provide a global signature of a patient that is able to derive disease
specific information. As discussed in this article, there is now great
potential for 2D-IR spectroscopy to follow suit, requiring further research
and understanding in how to apply to the field of clinical spectroscopy.
Going forward, the results of pivotal clinical trials will be telling for the
first of these technologies to translate into the clinic.
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